Release of acetylcholinesterase (AChE) from β-amyloid plaques assemblies improves the spatial memory impairments in APP-transgenic mice

Chemico-Biological Interactions

Volumn 175, Issue 1-3, 2008, Pages 142-149

  Dinamarca, Margarita C ^a   Arrázola, Macarena ^a   Toledo, Enrique ^a   Cerpa, Waldo F ^a   Hancke, Juan ^a   Inestrosa, Nibaldo C ^a  

^a MIFAB ^*  (Chile)

Author keywords

Acetylcholinesterase; Amyloid plaques; Amyloid peptide; IDN 5706; Neurotoxicity

Indexed keywords

ACETYLCHOLINESTERASE; ACYLPHOROGLUCINOL; AMYLOID BETA PROTEIN; CHAPERONE; HYPERFORIN; HYPERICUM PERFORATUM EXTRACT; IDN 5706; TETRAHYDROHYPERFORIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME RELEASE; HYPERICUM PERFORATUM; MEMORY DISORDER; MOUSE; NEUROTOXICITY; NONHUMAN; PROTEIN ASSEMBLY; SENILE PLAQUE; SPATIAL MEMORY; TRANSGENIC MOUSE;

ACETYLCHOLINESTERASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; IMMUNOHISTOCHEMISTRY; MEMORY DISORDERS; MICE; MICE, TRANSGENIC;

HYPERICUM PERFORATUM; MUS MUSCULUS;

EID: 50949100957     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.05.026     Document Type: Article

References (35)

1. Salmon D.P., and Bondi M.W. In: Terry R.D., Katzman R., Bick K.L., and Sisodia S.S. (Eds). Neuropsychology of Alzheimer Disease (1999), Lippincott Williams and Wilkins, Philadelphia 39-56
2. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 8 (2001) 741-766
3. Morgan C., Colombres M., Nunez M.T., and Inestrosa N.C. Structure and function of amyloid in Alzheimer's disease. Prog. Neurobiol. 74 (2004) 323-349
4. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16 (1996) 921-932
5. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 430 (2004) 631-639
6. Cruz L., Urbanc B., Buldyrev S.V., Christie R., Gomez-Isla T., Havlin S., et al. Aggregation and disaggregation of senile plaques in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 7612-7616
7. Walsh D.M., and Selkoe D.J. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44 (2004) 181-193
8. Harper J.D., and Lansbury Jr. P.T. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66 (1997) 385-407
9. Geula, Mesulam, Geula C., and Mesulam M.M. Cholinergic system in Alzheimer's disease. In: Terry R.D. (Ed). Alzheimer Disease. 2nd ed. (1999), Lippincot, Williams and Wilkins, Philadelphia, PA 69-292
10. Inestrosa N.C., and Perelman A. Distribution and anchoring of molecular forms of acetylcholinesterase. Trends Pharmacol. Sci. 10 (1989) 325-329
11. Grisaru D., Sternfeld M., Eldor A., Glick D., and Soreq H. Structural roles of acetylcholinesterase variants in biology and pathology. Eur. J. Biochem. 264 (1999) 672-686
12. Inestrosa N.C., Silberstein L., and Hall Z.W. Association of the synaptic form of acetylcholinesterase with extracellular matrix in cultured mouse muscle cells. Cell 29 (1982) 71-79
13. Inestrosa N.C., Alvarez A., and Calderon F. Acetylcholinesterase is a senile plaque component that promotes assembly of amyloid β-peptide into Alzheimer's filaments. Mol. Psychiatry 1 (1996) 359-361
14. Chacon M.A., Reyes A.E., and Inestrosa N.C. Acetylcholinesterase induces neuronal cell loss, astrocyte hypertrophy and behavioral deficits in mammalian hippocampus. J. Neurochem. 87 (2003) 195-204
15. Reyes A.E., Chacon M.A., Dinamarca M.C., Cerpa W., Morgan C., and Inestrosa N.C. Acetylcholinesterase-Aβ complexes are more toxic than Aβ fibrils in rat hippocampus: effect on rat β-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss. Am. J. Pathol. 164 (2004) 2163-2174
16. Morgan C., Bugueño M., Garrido J., and Inestrosa N.C. Laminin affects polymerization, depolymerization and neurotoxicity of Aβ peptide. Peptides 23 (2002) 1229-1240
17. Ono K., Yoshiike Y., Takashima A., Hasegawa K., Naiki H., and Yamada M. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease. J. Neurochem. 87 (2003) 172-181
18. Solomon B., Koppel R., Frankel D., and Hanan-Aharon E. Disaggregation of Alzheimer β-amyloid by site-directed mAβ. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4109-4112
19. Luo Y., Smith J.V., Paramasivam V., Burdick A., Curry K.J., Buford J.P., et al. Inhibition of amyloid-β-aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 12197-12202
20. Chacon M.A., Barria M.I., Soto C., and Inestrosa N.C. β-Sheet breaker peptide prevents Aβ-induced spatial memory impairments with partial reduction of amyloid deposits. Mol. Psychiatry 9 (2004) 953-961
21. Dinamarca M.C., Cerpa W., Garrido J., Hancke J.L., and Inestrosa N.C. Hyperforin prevents β-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-β-deposits. Mol. Psychiatry 11 (2006) 1032-1048
22. +. J. Pharmacol. Exp. Ther. 290 (1999) 1363-1368
23. Klusa V., Germane S., Noldner M., and Chatterjee S.S. Hypericum extract and hyperforin: memory-enhancing properties in rodents. Pharmacopsychiatry 34 (2001) S61-69
24. LeVine H. Thioflavin T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2 (1993) 404-410
25. Naiki H., Higuchi K., Nakakuki K., and Takeda T. Kinetic analysis of amyloid fibril polymerization in vitro. Lab. Invest. 65 (1991) 104-110
26. Ellman G.l., Courtney K.D., Andres Jr. V., and Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
27. Tago H., Kimura H., and Maeda T. Visualization of detailed acetylcholinesterase fiber and neuron staining in rat brain by a sensitive histochemical procedure. J. Histochem. Cytochem. 34 (1986) 1431-1438
28. Rees T.M., Berson A., Sklan E.H., Younkin L., Younkin S., Brimijoin S., and Soreq H. Memory deficits correlating with acetylcholinesterase splice shift and amyloid burden in doubly transgenic mice. Curr. Alzheimer Res. 2 (2005) 291-300
29. Dong H., Csernansky C.A., Martin M.V., Bertchume A., Vallera D., and Csernansky J.G. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease. Psychopharmacology 181 (2005) 145-152
30. Munoz-Ruiz P., Rubio L., Garcia-Palomero E., Dorronsoro I., del Monte-Millan M., Valenzuela R., Usan P., et al. Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease. J. Med. Chem. 48 (2005) 7223-7233
31. Munoz-Muriedas J., Lopez J.M., Orozco M., and Luque F.J. Molecular modelling approaches to the design of acetylcholinesterase inhibitors: new challenges for the treatment of Alzheimer's disease. Curr. Pharm. Des. 10 (2004) 3131-3140
32. Bolognesi M.L., Bartolini M., Cavalli A., Andrisano V., Rosini M., Minarini A., and Melchiorre C. Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues. J. Med. Chem. 47 (2004) 5945-5952
33. Belluti F., Rampa A., Piazzi L., Bisi A., Gobbi S., Bartolini M., Andrisano V., Cavalli A., Recanatini M., and Valenti P. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced β-amyloid aggregation. J. Med. Chem. 48 (2005) 4444-4456
34. Bourne Y., Kolb H.C., Radic Z., Sharpless K.B., Taylor P., and Marchot P. Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 1449-1454
35. Kryger G., Silman I., and Sussman J.L. Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo californica. J. Physiol. Paris 92 (1998) 191-194